MiR-214–3p regulates Piezo1, lysyl oxidases and mitochondrial function in human cardiac fibroblasts
Matrix Biology · 2024
DOI: 10.1016/j.matbio.2024.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Matrix Biology, 2024. Verfasst von Christopher J Trevelyan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds LS2 9JT, UK. Hauptthemen laut MEDLINE: MicroRNAs, Fibroblasts, Ion Channels. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Cardiac fibroblasts are pivotal regulators of cardiac homeostasis and are essential in the repair of the heart after myocardial infarction (MI), but their function can also become dysregulated, leading to adverse cardiac remodelling involving both fibrosis and hypertrophy. MicroRNAs (miRNAs) are noncoding RNAs that target mRNAs to prevent their translation, with specific miRNAs showing differential expression and regulation in cardiovascular disease. Here, we show that miR-214-3p is enriched in the fibroblast fraction of the murine heart, and its levels are increased with cardiac remodelling associated with heart failure, or in the acute phase after experimental MI. Tandem mass tagging proteomics and in-silico network analyses were used to explore protein targets regulated by miR-214-3p in cultured human cardiac fibroblasts from multiple donors. Overexpression of miR-214-3p by miRNA mimics resulted in decreased expression and activity of the Piezo1 mechanosensitive cation channel, increased expression of the entire lysyl oxidase (LOX) family of collagen cross-linking enzymes, and decreased expression of an array of mitochondrial proteins, including mitofusin-2 (MFN2), resulting in mitochondrial dysfunction, as measured by citrate synthase and Seahorse mitochondrial respiration assays. Collectively, our data suggest that miR-214-3p is an important regulator of cardiac fibroblast phenotypes and functions key to cardiac remodelling, and that this miRNA represents a potential therapeutic target in cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds LS2 9JT, UK.
- Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds LS2 9JT, UK; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS…
- School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
- Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds LS2 9JT, UK. Electronic address: n.a.turner@leeds.ac.uk.
Förderung
- British Heart Foundation
Zitieren
APA
Trevelyan, C. J., MacCannell, A. D. V., Stewart, L., Tarousa, T., Taylor, H. A., Murray, M., Bageghni, S. A., Hemmings, K. E., Drinkhill, M. J., Roberts, L. D., Smith, A. J., Porter, K. E., Forbes, K. A., & Turner, N. A. (2024). MiR-214–3p regulates Piezo1, lysyl oxidases and mitochondrial function in human cardiac fibroblasts. Matrix Biology. https://doi.org/10.1016/j.matbio.2024.06.005
Vancouver
Trevelyan CJ, MacCannell ADV, Stewart L, Tarousa T, Taylor HA, Murray M, et al. MiR-214–3p regulates Piezo1, lysyl oxidases and mitochondrial function in human cardiac fibroblasts. Matrix Biology. 2024. doi:10.1016/j.matbio.2024.06.005
BibTeX
@article{Trevelyan2024,
author = {Trevelyan, Christopher J and MacCannell, Amanda D V and Stewart, Leander and Tarousa, Theodora and Taylor, Hannah A and Murray, Michael and Bageghni, Sumia A and Hemmings, Karen E and Drinkhill, Mark J and Roberts, Lee D and Smith, Andrew J and Porter, Karen E and Forbes, Karen A and Turner, Neil A},
title = {MiR-214–3p regulates Piezo1, lysyl oxidases and mitochondrial function in human cardiac fibroblasts},
journal = {Matrix Biology},
year = {2024},
doi = {10.1016/j.matbio.2024.06.005}
}
EUVIMED